Rangering i aksjer
#34230
Sesen Bio, Inc. is a clinical-stage biotechnology firm deeply involved in the... Sesen Bio, Inc. is a clinical-stage biotechnology firm deeply involved in the creation, advancement, and eventual market launch of targeted fusion protein therapeutics (TFPTs). Their primary aim is to combat various forms of cancer. Their flagship experimental drug, Vicineum, is a locally administered targeted fusion protein currently undergoing Phase III clinical trials. It targets several conditions, including non-muscle invasive bladder cancer that has not responded to bacillus Calmette-Guérin (BCG) treatment, non-muscle invasive carcinoma in situ of the bladder in patients who previously received BCG, and squamous cell carcinoma affecting the head and neck region. Another promising candidate, VB6-845d, is being developed to address a range of anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio is also collaborating with Leiden University Medical Center on the joint development of an imaging agent. Originally incorporated in 2008, the company operated as Eleven Biotherapeutics, Inc. before rebranding as Sesen Bio, Inc. in May 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.
Aksjekurs
$0.6288
Sist synkronisert: 2023-03-07
Handel Sesen Bio, Inc. (SESN)
Pris SESN pris med markedsverdi på B
Markedsverdi av Sesen Bio, Inc.(SESN)
Markedsverdi: $6.00M
Per August 2026 har Sesen Bio, Inc. en markedsverdi på $6.00M. Dette gjør Sesen Bio, Inc. til det 34230th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Sesen Bio, Inc. fra 2018 til 2026
SESN sammenlignet med topp 5 mest populære stocks
| Pris på SESN |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+90,832,241.65%
|
|
|
|
|
$4.490T
|
+74,807,115.79%
|
|
|
|
|
$4.162T
|
+69,348,826.81%
|
|
|
|
|
$3.676T
|
+61,250,614.21%
|
|
|
|
|
$2.833T
|
+47,200,585.76%
|
